Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antihypertensive persistence and drug class.

Michael A Marentette1, William C Gerth, David K Billings

  • 1Merck Frosst Canada Ltd, Kirkland, Canada. michael_marentette@merck.com

The Canadian Journal of Cardiology
|July 11, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prediction of major postoperative events after non-cardiac surgery for people with kidney failure: derivation and internal validation of risk models.

BMC nephrology·2023
Same author

Perioperative management for people with kidney failure receiving dialysis: A scoping review.

Seminars in dialysis·2022
Same author

Mortality and cardiovascular events in adults with kidney failure after major non-cardiac surgery: a population-based cohort study.

BMC nephrology·2021
Same author

Sequential measurement of the neurosensory retina in hypertensive disorders of pregnancy: a model of microvascular injury in hypertensive emergency.

Journal of human hypertension·2021
Same author

Derivation and External Validation of a Risk Index for Predicting Acute Kidney Injury Requiring Kidney Replacement Therapy After Noncardiac Surgery.

JAMA network open·2021
Same author

The Perioperative Surgical Home, Enhanced Recovery After Surgery and how integration of these models may improve care for medically complex patients.

Canadian journal of surgery. Journal canadien de chirurgie·2021

Hypertension drug persistence varied by class, with angiotensin II antagonists showing the highest patient adherence. Persistence decreased over time, but females and elderly patients were more compliant with antihypertensive therapy.

Area of Science:

  • Cardiovascular medicine
  • Pharmacology
  • Health services research

Background:

  • Noncompliance with antihypertensive therapy is a significant barrier to effective hypertension management.
  • Understanding drug persistence is crucial for improving patient outcomes in hypertension care.

Purpose of the Study:

  • To investigate antihypertensive drug persistence among hypertensive patients in real-world clinical settings.
  • To compare persistence rates across different classes of antihypertensive medications.

Main Methods:

  • Retrospective study of 46,458 hypertensive patients from 1994-1998 using Saskatchewan Health databases.
  • Categorization of antihypertensive prescriptions into five drug classes: angiotensin II antagonists, ACE inhibitors, beta-blockers, calcium channel blockers, and diuretics.

Related Experiment Videos

  • Assessment of drug persistence at 180, 360, 540, and 720 days.

    • Main Results:

    • Drug class significantly impacted persistence (P<0.001), with angiotensin II antagonists demonstrating the highest rates.
    • Persistence declined over the observed time intervals.
    • Females and elderly patients exhibited significantly higher persistence than males and younger patients, respectively (P<0.005 and P<0.001).

    Conclusions:

    • The superior persistence with angiotensin II antagonists suggests a potential for improved hypertension management.
    • Tailoring therapy based on patient demographics may enhance adherence and treatment efficacy.